Tactile Cueing for Parkinson's Disease
(cueing Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore how a new tactile cueing system can help people with Parkinson's Disease (PD) improve their walking. Participants will test two types of cueing: one that adjusts to each step (personalized tactile cueing) and another that uses a steady rhythm (fixed tactile cueing). The goal is to determine if these cues can make walking feel more automatic and less mentally taxing. This study may suit those diagnosed with Parkinson's who experience issues like tremors or balance problems but do not have other conditions affecting their walking. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance daily life for those with Parkinson's.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently using dopamine-blocking agents or cholinesterase inhibitors.
What prior data suggests that this tactile cueing system is safe for people with Parkinson's Disease?
Research shows that touch-based cues, both personalized and fixed, are generally safe for people with Parkinson's Disease. Earlier studies have demonstrated that personalized touch cues, such as vibrations matching a person's steps, offer potential benefits without major safety issues. These cues aim to improve walking by providing real-time feedback through vibrations.
For fixed touch cues, studies indicate they are well-tolerated. A review found that this method could enhance walking speed and step length in Parkinson's patients during dual-task activities, without significant side effects. Another study on a similar device called CUE1 found it safe and easy to use, suggesting it might be a promising non-invasive treatment option.
Both methods enhance the brain's understanding of the body's position and movement. Overall, evidence suggests these touch-based cues are safe and may help improve walking in people with Parkinson's.12345Why are researchers excited about this trial?
Researchers are excited about these tactile cueing methods for Parkinson's disease because they offer innovative ways to enhance movement. Unlike traditional treatments that mainly focus on medication to manage symptoms, these methods use tactile feedback to improve gait. Personalized cueing adapts in real-time to a person's walking pattern, providing synchronized feedback that could lead to more natural movement. On the other hand, fixed cueing provides consistent rhythmic feedback, which might help some patients maintain a stable walking rhythm. Both approaches could offer new, non-pharmacological options to help patients regain better control over their movements.
What evidence suggests that this trial's tactile cueing treatments could be effective for Parkinson's Disease?
This trial will compare two types of tactile cueing for Parkinson's disease: personalized and fixed. Research has shown that touch-based signals can improve movement in people with Parkinson's disease. For personalized touch signals, which participants in this trial may receive, studies suggest they might reduce activity in the prefrontal cortex, potentially making walking feel more natural. They also seem to enhance the smoothness and speed of walking. For fixed touch signals, another treatment option in this trial, the evidence is not as strong, but some research suggests they might help increase walking speed and step length in certain situations. Overall, devices using touch signals show promise in improving movement for Parkinson's patients.12367
Who Is on the Research Team?
Martina Mancini, PhD
Principal Investigator
Oregon Health and Science University
Are You a Good Fit for This Trial?
This trial is for people with Parkinson's Disease who can walk and follow instructions. They must be diagnosed by a specialist, not have other serious nervous system issues besides PD, and be at specific stages of the disease where symptoms are moderate.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized into one of two cueing interventions: personalized, step-synchronized tactile cueing or tactile cueing at fixed intervals.
Follow-up
Participants are monitored for retention of gait and turning improvements with a third week of continuous monitoring.
Extension
Exploration of the feasibility and potential benefits of independent use of tactile cueing during a week in daily life.
What Are the Treatments Tested in This Trial?
Interventions
- Fixed tactile cueing
- Personalized tactile cueing
Find a Clinic Near You
Who Is Running the Clinical Trial?
Oregon Health and Science University
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator